Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 3
2003 2
2005 3
2006 3
2007 4
2008 4
2009 3
2010 5
2011 2
2012 2
2013 2
2014 2
2015 4
2016 2
2017 1
2018 5
2019 3
2020 6
2021 8
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

63 results
Results by year
Filters applied: . Clear all
Page 1
Genome-wide CRISPR-Cas9 screening reveals ubiquitous T cell cancer targeting via the monomorphic MHC class I-related protein MR1.
Crowther MD, Dolton G, Legut M, Caillaud ME, Lloyd A, Attaf M, Galloway SAE, Rius C, Farrell CP, Szomolay B, Ager A, Parker AL, Fuller A, Donia M, McCluskey J, Rossjohn J, Svane IM, Phillips JD, Sewell AK. Crowther MD, et al. Among authors: parker al. Nat Immunol. 2020 Feb;21(2):178-185. doi: 10.1038/s41590-019-0578-8. Epub 2020 Jan 20. Nat Immunol. 2020. PMID: 31959982 Free PMC article.
Precision virotherapies: Coming soon.
Uusi-Kerttula H, Parker AL. Uusi-Kerttula H, et al. Among authors: parker al. Oncotarget. 2018 Nov 2;9(86):35605-35606. doi: 10.18632/oncotarget.26280. eCollection 2018 Nov 2. Oncotarget. 2018. PMID: 30479689 Free PMC article. No abstract available.
Designer Oncolytic Adenovirus: Coming of Age.
Baker AT, Aguirre-Hernández C, Halldén G, Parker AL. Baker AT, et al. Among authors: parker al. Cancers (Basel). 2018 Jun 14;10(6):201. doi: 10.3390/cancers10060201. Cancers (Basel). 2018. PMID: 29904022 Free PMC article. Review.
Superlensing microscope objective lens.
Yan B, Wang Z, Parker AL, Lai YK, John Thomas P, Yue L, Monks JN. Yan B, et al. Among authors: parker al. Appl Opt. 2017 Apr 10;56(11):3142-3147. doi: 10.1364/AO.56.003142. Appl Opt. 2017. PMID: 28414373
63 results